Nadolol Tablets — Class II drug recall D-0236-2017
Terminated recall by Sandoz Incorporated, reported 2017-01-04, distributed in MS, OH. Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specifica
| Recall number | D-0236-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Sandoz Incorporated, Broomfield, CO, United States |
| Recall initiated | 2016-12-22 |
| Classified | 2016-12-27 |
| Reported by FDA | 2017-01-04 |
| Terminated | 2017-09-18 |
| Distributed | MS, OH |
| Quantity | 96 bottles |
| Reason classes | specification failure |
| NDC | 00781-1182-10 |
| Lot numbers | GG1539 |
Product
Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDC 0781-1182-10
Reason for recall
Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%)
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0236-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.